Moreover, patients with Alzheimer's disease, the most common type of dementia, have high TNF-α levels (12), and perispinal etanercept (a TNF inhibitor) has been shown to rapidly improve verbal fluency and aphasia in patients with Alzheimer's disease (13). The gene discussed is TNF; the disease is early-onset autosomal dominant Alzheimer disease.